Sato H - Search Results

1

Entry of the new quinolone antibacterial agents of ofloxacin and NY-198 into the central nervous system in rats.

Sato H, Okezaki E, Yamamoto S, Nagata O, Kato H, Tsuji A. Sato H, et al. J Pharmacobiodyn. 1988 Jun;11(6):386-94. doi: 10.1248/bpb1978.11.386. J Pharmacobiodyn. 1988. PMID: 3171880

2

Effect of a diffusional barrier to a metabolite across hepatocytes on its kinetics in "enzyme-distributed" models: a computer-aided simulation study.

Miyauchi S, Sugiyama Y, Sato H, Sawada Y, Iga T, Hanano M. Miyauchi S, et al. Among authors: sato h. J Pharmacokinet Biopharm. 1987 Aug;15(4):399-421. doi: 10.1007/BF01066521. J Pharmacokinet Biopharm. 1987. PMID: 3681667

3

Kinetics of peritoneal drug transport in rats: an application of the pore theory of transcapillary exchange.

Nakashima E, Ishikawa F, Sato H, Deguchi Y, Tamai I, Matsushita R, Ichimura F, Tsuji A. Nakashima E, et al. Among authors: sato h. J Pharm Sci. 1988 Jun;77(6):481-8. doi: 10.1002/jps.2600770604. J Pharm Sci. 1988. PMID: 3171925

4

Physiologically based pharmacokinetics of radioiodinated human beta-endorphin in rats. An application of the capillary membrane-limited model.

Sato H, Sugiyama Y, Sawada Y, Iga T, Hanano M. Sato H, et al. Drug Metab Dispos. 1987 Jul-Aug;15(4):540-50. Drug Metab Dispos. 1987. PMID: 2888629

5

Effect of the anti-inflammatory agent fenbufen on the quinolone-induced inhibition of gamma-aminobutyric acid binding to rat brain membranes in vitro.

Tsuji A, Sato H, Okezaki E, Nagata O, Kato H. Tsuji A, et al. Among authors: sato h. Biochem Pharmacol. 1988 Nov 15;37(22):4408-11. doi: 10.1016/0006-2952(88)90625-9. Biochem Pharmacol. 1988. PMID: 2848527 No abstract available.

6

Inhibitory effects of quinolone antibacterial agents on gamma-aminobutyric acid binding to receptor sites in rat brain membranes.

Tsuji A, Sato H, Kume Y, Tamai I, Okezaki E, Nagata O, Kato H. Tsuji A, et al. Among authors: sato h. Antimicrob Agents Chemother. 1988 Feb;32(2):190-4. doi: 10.1128/AAC.32.2.190. Antimicrob Agents Chemother. 1988. PMID: 2834994 Free PMC article.

7

Application of HPLC in disposition study of A14-125I-labeled insulin in mice.

Sato H, Tsuji A, Hirai K, Kang YS. Sato H, et al. Diabetes. 1990 May;39(5):563-9. doi: 10.2337/diab.39.5.563. Diabetes. 1990. PMID: 2185107

8

Specific binding of beta-endorphin to the isolated renal basolateral membranes in vitro.

Sato H, Takeda K, Terasaki T, Tsuji A. Sato H, et al. Chem Pharm Bull (Tokyo). 1990 Dec;38(12):3395-9. doi: 10.1248/cpb.38.3395. Chem Pharm Bull (Tokyo). 1990. PMID: 2092936

9

Receptor-mediated endocytosis of A14-125I-insulin by the nonfiltering perfused rat kidney.

Sato H, Yoshioka K, Terasaki T, Tsuji A. Sato H, et al. Biochim Biophys Acta. 1991 Apr 9;1073(3):442-50. doi: 10.1016/0304-4165(91)90213-z. Biochim Biophys Acta. 1991. PMID: 2015267

10

Specific binding and clearance of [3H]dynorphin (1-13) in the perfused rat lung: an application of the multiple-indicator dilution method.

Sato H, Terasaki T, Tsuji A. Sato H, et al. J Pharm Pharmacol. 1990 Dec;42(12):879-82. doi: 10.1111/j.2042-7158.1990.tb07047.x. J Pharm Pharmacol. 1990. PMID: 1983155

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results